These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9337530)

  • 1. Tissue factor pathway inhibitor (TFPI).
    Rucińska M; Gacko M; Skrzydlewski Z
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():118-22. PubMed ID: 9337530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tissue factor pathway inhibitor (TFPI) and its role in pathology].
    Rucińska M; Gacko M; Skrzydlewski Z
    Postepy Hig Med Dosw; 1997; 51(4):421-30. PubMed ID: 9446103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor pathway inhibitor; its structure, function and clinical significance.
    Kato H
    Pol J Pharmacol; 1996; 48(1):67-72. PubMed ID: 9112630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
    Iakhiaev A; Ruf W; Rao LV
    Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
    Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and biology of tissue factor pathway inhibitor.
    Bajaj MS; Birktoft JJ; Steer SA; Bajaj SP
    Thromb Haemost; 2001 Oct; 86(4):959-72. PubMed ID: 11686353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of depolymerized holothurian glycosaminoglycan (DHG) on tissue factor pathway inhibitor: in vitro and in vivo studies.
    Nagase H; Enjyoji K; Kamikubo Y; Kitazato KT; Kitazato K; Saito H; Kato H
    Thromb Haemost; 1997 Aug; 78(2):864-70. PubMed ID: 9268186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor Xa cleavage of tissue factor pathway inhibitor is associated with loss of anticoagulant activity.
    Salemink I; Franssen J; Willems GM; Hemker HC; Li A; Wun TC; Lindhout T
    Thromb Haemost; 1998 Aug; 80(2):273-80. PubMed ID: 9716152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of secreted Kunitz domain 1 variants of tissue factor pathway inhibitor.
    Johnson K; Zaror I; Bauer D; Choi Y; Creasey A; Innis M
    Thromb Haemost; 1998 Oct; 80(4):585-7. PubMed ID: 9798974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8.
    Cunningham AC; Hasty KA; Enghild JJ; Mast AE
    Biochem J; 2002 Oct; 367(Pt 2):451-8. PubMed ID: 12117418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin.
    Wesselschmidt R; Likert K; Huang Z; MacPhail L; Broze GJ
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):661-9. PubMed ID: 8292716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The present status of tissue factor pathway inhibitor.
    Lindahl AK; Sandset PM; Abildgaard U
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):439-49. PubMed ID: 1420819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant tissue factor pathway inhibitor enhances the binding of factor Xa to human monocytes.
    Li A; Chang AC; Peer GT; Wun TC; Taylor FB
    Thromb Haemost; 2001 May; 85(5):830-6. PubMed ID: 11372676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis.
    Kaikita K; Takeya M; Ogawa H; Suefuji H; Yasue H; Takahashi K
    J Pathol; 1999 Jun; 188(2):180-8. PubMed ID: 10398162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa.
    Burgering MJ; Orbons LP; van der Doelen A; Mulders J; Theunissen HJ; Grootenhuis PD; Bode W; Huber R; Stubbs MT
    J Mol Biol; 1997 Jun; 269(3):395-407. PubMed ID: 9199408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.
    Hackeng TM; Seré KM; Tans G; Rosing J
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3106-11. PubMed ID: 16488980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protamine neutralization of the release of tissue factor pathway inhibitor activity by heparins.
    Harenberg J; Siegele M; Dempfle CE; Stehle G; Heene DL
    Thromb Haemost; 1993 Dec; 70(6):942-5. PubMed ID: 8165616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor.
    Lindhout T; Franssen J; Willems G
    Thromb Haemost; 1995 Sep; 74(3):910-5. PubMed ID: 8571320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of tissue factor and its inhibitor in hemostasis].
    Naumnik B; Małyszko J; Myśliwiec M
    Przegl Lek; 1998; 55(2):68-73. PubMed ID: 9695646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.